Population pharmacokinetics of phenobarbital in infants with neonatal encephalopathy treated with therapeutic hypothermia

Pediatric Critical Care Medicine

Volumn 14, Issue 2, 2013, Pages 194-202

  Shellhaas, Renée A ^a   Ng, Chee M ^b,c   Dillon, Christina H ^d   Barks, John D E ^a   Bhatt Mehta, Varsha ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

neonatal encephalopathy; neonates; pharmacokinetics; Phenobarbital; seizures; therapeutic hypothermia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PHENOBARBITAL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; APGAR SCORE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIRTH WEIGHT; BODY TEMPERATURE; BODY WEIGHT; CHILD GROWTH; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; GESTATIONAL AGE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; LIVER FUNCTION TEST; MALE; NEUROPROTECTION; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; TREATMENT RESPONSE;

AGE FACTORS; ANTICONVULSANTS; BODY TEMPERATURE; BODY WEIGHT; FEMALE; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; MALE; PHENOBARBITAL; RETROSPECTIVE STUDIES; SEIZURES;

EID: 84873887171     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31825bbbc2     Document Type: Article

References (31)

1. Gluckman PD, Wyatt JS, Azzopardi D, et al: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: Multicentre randomised trial. Lancet 2005; 365:663-670
2. Shankaran S, Laptook AR, Ehrenkranz RA, et al; National Institute of Child Health and Human Development Neonatal Research Network: Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353:1574-1584
3. Wyatt JS, Gluckman PD, Liu PY, et al; CoolCap Study Group: Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 2007; 119:912-921
4. Bartha AI, Shen J, Katz KH, et al: Neonatal seizures: Multicenter variability in current treatment practices. Pediatr Neurol 2007; 37:85-90
5. Blume HK, Garrison MM, Christakis DA: Neonatal seizures: Treatment and treatment variability in 31
6. United States pediatric hospitals. J Child Neurol 2009; 24:148-154
7. Painter MJ, Scher MS, Stein AD, et al: Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med 1999; 341:485-489
8. Bittigau P, Sifringer M, Genz K, et al: Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002; 99:15089-15094
9. Azzopardi DV, Strohm B, Edwards AD, et al; TOBY Study Group: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361:1349-1358
10. Zanelli S, Buck M, Fairchild K: Physiologic and pharmacologic considerations for hypothermia therapy in neonates. J Perinatol 2010; 31: 1-10
11. Tortorici MA, Kochanek PM, Bies RR, et al: Therapeutic hypothermiainduced pharmacokinetic alterations on CYP2E1
12. chlorzoxazone-mediated metabolism in a cardiac arrest rat model. Crit Care Med 2006; 34: 785-791
13. Roka A, Melinda KT, Vasarhelyi B, et al: Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy. Pediatrics 2008; 121:e844-e849
14. Hvidberg EF, Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet 1976; 1:161-188
15. Mann MW, Pons G: Various pharmacogenetic aspects of antiepileptic drug therapy: A review. CNS Drugs 2007; 21:143-164
16. Kwan P: Antiepileptic drug research in Asia: Where do we go from here? Neurol J Southeast Asia 2003; 8:81-85
17. Sarkar S, Barks JD, Bhagat I, et al: Effects of therapeutic hypothermia on multiorgan dysfunction in asphyxiated newborns: Whole-body cooling versus selective head cooling. J Perinatol 2009; 29:558-563
18. Anderson BJ, McKee AD, Holford NH: Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients. Clin Pharmacokinet 1997; 33:313-327
19. West GB, Brown JH, Enquist BJ: Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance. Br J Clin Pharmacol 1999; 63:75-84
20. Liu X, Borooah M, Stone J, et al: Serum gentamicin concentrations in encephalopathic infants are not affected by therapeutic hypothermia. Pediatrics 2009; 124:310-315
21. Satas S, Hoem NO, Melby K, et al: Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs. Biol Neonate 2000; 77:50-57
22. Stone AN, Mackenzie PI, Galetin A, et al: Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp- glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7. Drug Metab Dispos 2003; 31:1086-1089
23. Alonso GAC, Ortega VL, Santos BD, et al: Dosage programming of phenobarbital in neonatal seizures. J Clin Pharm Therap 1993; 18:267-270
24. Heimann G, Gladtke E: Pharmacokinetics of phenobarbital in childhood. Eur J Clin Pharmacol 1977; 12:305-310
25. Pitlick W, Painter M, Pippenger C: Phenobarbital pharmacokinetics in neonates. Clin Pharmacol Ther 1978; 23:346-350
26. Takemoto CK, Hodding JH, Kraus DM (Eds.): The Pediatric Dosage Handbook. 16
27. Grasela TH Jr, Donn SM: Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. Dev Pharmacol Ther 1985; 8:374-383
28. Filippi L, la Marca G, Cavallaro G, et al: Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: A pharmacokinetic study during whole body hypothermia. Epilepsia 2011; 52:794-801
29. Tokugawa K, Ueda K, Fujito H, et al: Correlation between the saliva and free serum concentration of phenobarbital in epileptic children. Eur J Pediatr 1986; 145:401-402
30. Nishihara K, Uchino K, Saitoh Y, et al: Estimation of plasma unbound phenobarbital concentration by using mixed saliva. Epilepsia 1979; 20:37-45
31. Yukawa E, Suematsu F, Yukawa M, et al: Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants. J Clin Pharm Ther 2005; 30:159-163